2022_Sep_ConnectinPharma_Easyfairs_Geneva

Panarum

Panarum Corporation is developing its Proteoral® technology for the delivery of therapeutic polypeptides, which works by innocuously opening intercellular junctions of the intestinal epithelium. The company is privately owned. It was founded in 2017 with investments from angel investors.


Visit Website

Headquarters
Panarum Corporation
Av Independencia 3150
CP 1225
Buenos Aires
Argentina

Phone / Contact

E: info@panarum.com

Connect

Panarum Corporation is developing its Proteoral® technology for the delivery of therapeutic polypeptides, which works by innocuously opening intercellular junctions of the intestinal epithelium.

The company is privately owned. It was founded in 2017 with investments from angel investors. In 2020 it secured its first international venture capital investment.

Top